Bayer AG Archives - Executive Platforms: Thought Leader Series

Panel: Biotech Manufacturing Industrialization, Talent Development, and Leadership — A Tribute to Our Friend Mike Kamarck

November 22, 2023

Over the last few decades we have all witnessed the industrialization of biologics manufacturing, as well as continuous progress in complex medicines such as Cell and Gene Therapy. In this panel we will reflect on where we started, where we are now, and what our future holds. We dedicate this conversation to Mike Kamarck, an exceptional leader of our era whose legacy includes everything we plan to discuss: Alison MooreCMC Executive Dr. Alison Moore is a CMC Executive who most recently served as the Chief Technical Officer at Allogene Therapeutics. Prior to this role, Moore served as Senior Vice President,…

Transforming a Global Development & Product Supply Network for Delivering a Multi-Modal Portfolio – It’s More than Flexible Facilities

May 26, 2023

Re-designing your organization to leverage capabilities across modalities In agile ways Designing technology platforms as you design products Laying the foundation for change during a pandemic builds flexibility and resilience in employees, setting the course for new ways of working and breaking down silos Strengthening a culture of inclusion and driving diversity in leadership ranks — Jens Vogel SVP & Global Head of Biotech Bayer Pharmaceuticals Dr. Jens Vogel rejoined Bayer in March of 2020 as Global Head of Biotech for the Bayer Pharmaceuticals Product Supply organization. He has more than 20 years of professional and leadership experience in the…

Pharmaceutical Development and Manufacturing — The New Post-Pandemic Realities

April 8, 2022

Discussing how the business model change accelerates Highlighting transformation needs in business setup, technology and ways of working Impact on Development and Manufacturing of different modalities How does Bayer gets prepared for such opportunities and challenges? — Wolfram Carius EVP Pharmaceuticals Bayer AG Prof. Wolfram Carius is the EVP Pharmaceuticals at Bayer AG and is a member of the Executive Committee for Bayer Pharmaceuticals. He is based in Berlin, Germany. Prior to joining Bayer, Wolfram was a corporate senior vice president and member of the global leadership team at Sanofi Genzyme for nearly three years. Before that, he worked for…

6 Comments

LIFE SCIENCES, LIFE SCIENCES, VIDEO

How to Make the Bio-Revolution a Reality: Building Bayer’s Cell & Gene Therapy Platform

November 30, 2021

How Bayer AG built its Cell & Gene Therapy unit New business model joining best of Biotech and best of Pharma How to build a sustainable pipeline? How to manage complexity and keep focus? What are the “must haves”? what are the learnings on common threats of significant transformations? New ways of working accelerated by COVID-19 pandemic Wolfram Carius EVP, Cell and Gene Therapy Bayer AG Prof. Wolfram Carius is the EVP, Cell and Gene Therapy at Bayer AG and is a member of the Executive Committee for Bayer Pharmaceuticals. He is based in Berlin, Germany. Prior to joining Bayer,…

Bayer AG

Panel: Biotech Manufacturing Industrialization, Talent Development, and Leadership — A Tribute to Our Friend Mike Kamarck

Pharmaceutical Development and Manufacturing — The New Post-Pandemic Realities

How to Make the Bio-Revolution a Reality: Building Bayer’s Cell & Gene Therapy Platform

NASCES

NAFS

NAFMS

EUSCES

BMWS

NAFES

NASRS

NAMES

PMWS

NAISS

NAHRES

Categories

Newsletter